Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Zealand Pharma
  4. Zealand Pharma — November 2023

Zealand Pharma — November 2023

Planlagt Fastgjort Låst Flyttet Zealand Pharma
506 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #77

    Tja, nu må vi se, måske endda rigtigt godt!

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #78

      Luk i kurs 290,00 & +1,40% 🙂

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #79

        God morgen 🙂

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #80

          Godmorgen 🙂

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #81

            Klar til en god Zealand Pharma dag 🙂

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #82

              Dagens mange regnskaber: https://www.proinvestor.com/finanskalender

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Stroka
                wrote on sidst redigeret af
                #83

                God morgen 🙂

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #84

                  Lilly : FDA Approves Zepbound For Chronic Weight Management, New Option For Treatment Of Obesity https://www.proinvestor.com/investornyt/1076597/lilly-fda-approves-zepbound-for-chronic-weight-management-new-option-for-treatment-of-obesity

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    B.Andersen
                    wrote on sidst redigeret af
                    #85

                    Godmorgen til en spændende Zeal-dag. 🙂

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #86

                      ZEAL - Financial Results for the First Nine Mont of 2023 https://www.proinvestor.com/boards/116627

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        LP90
                        wrote on sidst redigeret af
                        #87

                        Godmorgen 🙂

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #88

                          "Financial

                          Solid financial position. * Milestone payments from existing partnerships were recognized in the third quarter of 2023, with cash inflow expected in the fourth quarter of 2023, contributing to the company's solid financial position. These potential milestones include EUR 30 million from Boehringer Ingelheim associated with survodutide and USD 10 million from Sanofi associated with lixisenatide".

                          1 Reply Last reply
                          0
                          • exitnuE Offline
                            exitnuE Offline
                            exitnu
                            wrote on sidst redigeret af
                            #89

                            "Finally, we will end this transformative year with a planned NDA submission for glepaglutide in short bowel syndrome and the first PDUFA date for dasiglucagon in congenital hyperinsulinism.”

                            1 Reply Last reply
                            0
                            • SvingtraderenS Offline
                              SvingtraderenS Offline
                              Svingtraderen
                              wrote on sidst redigeret af
                              #90

                              God morgen og tak for god update

                              1 Reply Last reply
                              0
                              • Y Offline
                                Y Offline
                                YPE
                                wrote on sidst redigeret af
                                #91

                                God morgen. evt godkendelse på CHI kommer d. 30. dec. 2023

                                1 Reply Last reply
                                0
                                • exitnuE Offline
                                  exitnuE Offline
                                  exitnu
                                  wrote on sidst redigeret af
                                  #92

                                  291 mio. DKK i milepælsbetalinger ... 🙂

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #93

                                    Zealand Pharma: Milepælsbetalinger skæppede pænt i kassen i tredje kvartal https://www.proinvestor.com/investornyt/1076634/zealand-pharma-milepaelsbetalinger-skaeppede-paent-i-kassen-i-tredje-kvartal

                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #94

                                      Zealand Pharma Announces Financial Results for the First Nine Months of 2023:

                                      https://ml-eu.globenewswire.com/Resource/Download/fe1d7624-d8d3-48d2-b499-430f27535d81

                                      (PDF)

                                      1 Reply Last reply
                                      0
                                      • exitnuE Offline
                                        exitnuE Offline
                                        exitnu
                                        wrote on sidst redigeret af
                                        #95

                                        "Dasiglucagon in CHI ... Zealand continues to engage in partnership discussions for commercialization of the product" &
                                        "... short bowel syndrome with intestinal failure and subsequently engage in more detailed partnership discussions"

                                        • Så JA, der er damp under kedlerne mht. detaljerede partnerskabsdrøftelser!
                                        1 Reply Last reply
                                        0
                                        • Y Offline
                                          Y Offline
                                          YPE
                                          wrote on sidst redigeret af
                                          #96

                                          Er det givet, at der kommer en partneraftale på CHI inden evt. godkendelse? Det synes jeg nemlig ikke at ZP skriver noget om. I sidste regnskab var target H2 2023.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper